Kashiwagi, K.; Jimbo, K.; Suzuki, M.; Arai, N.; Kudo, T.; Shimizu, T.
Impact of Anti-TNFα Treatment on the Humoral Response to the BNT162b2 mRNA COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease Patients. Vaccines 2022, 10, 1618.
https://doi.org/10.3390/vaccines10101618
AMA Style
Kashiwagi K, Jimbo K, Suzuki M, Arai N, Kudo T, Shimizu T.
Impact of Anti-TNFα Treatment on the Humoral Response to the BNT162b2 mRNA COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease Patients. Vaccines. 2022; 10(10):1618.
https://doi.org/10.3390/vaccines10101618
Chicago/Turabian Style
Kashiwagi, Kosuke, Keisuke Jimbo, Mitsuyoshi Suzuki, Nobuyasu Arai, Takahiro Kudo, and Toshiaki Shimizu.
2022. "Impact of Anti-TNFα Treatment on the Humoral Response to the BNT162b2 mRNA COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease Patients" Vaccines 10, no. 10: 1618.
https://doi.org/10.3390/vaccines10101618
APA Style
Kashiwagi, K., Jimbo, K., Suzuki, M., Arai, N., Kudo, T., & Shimizu, T.
(2022). Impact of Anti-TNFα Treatment on the Humoral Response to the BNT162b2 mRNA COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease Patients. Vaccines, 10(10), 1618.
https://doi.org/10.3390/vaccines10101618